Page 11 of 14
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
The product was purified according to Method A (Et2O eluent), and was isolated as a yellow oil
1
(121 mg, >99%). H NMR (400 MHz, CDCl3): δ 9.87 (s, 1H), 7.48 (dd, J = 7.8, 1.5 Hz, 1H),
7.40 – 7.21 (m, 1H), 6.74 (t, J = 7.8 Hz, 1H), 6.65 (d, J = 8.3 Hz, 1H), 6.11 (s, 2H). 13C NMR
(101 MHz, CDCl3) δ 194.0, 149.8, 135.7, 135.2, 118.8, 116.3, 116.0. Spectral properties are
consistent with literature values.12
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(Z)-4-benzyloxy-but-2-enal (3)
The reaction was performed in a flask covered with black electrical tape in a fume hood with
hood lights turned off. It is unnecessary to turn auxiliary laboratory lights off during the reaction.
Upon completion by TLC analysis, the product was purified according to Method A (EtOAc
eluent) with fume hood lights off. Rotary evaporation was performed in normal lab lighting. The
product was isolated as a pink oil (165 mg, 94%) and was stored in a glass vial covered with
black electrical tape. >20:1 Z:E by 1H NMR spectroscopy. 1H NMR (400 MHz, CDCl3) δ 10.05
(d, J = 6.8 Hz, 1H), 7.34 (m, 5H), 6.64 (dt, J = 11.2, 5.6 Hz, 1H), 6.06 (ddt, J = 11.2, 6.8, 2.0 Hz,
13
1H), 4.59 (s, 2H), 4.53 (dd, J = 5.6, 2.0 Hz, 2H). C NMR (101 MHz, CDCl3) δ 191.6, 147.7,
137.5, 129.9, 128.8, 128.2, 128.0, 73.3, 67.2.
Spectral properties are consistent with literature values.13
3-benzyloxy-propionaldehyde (4)
The product was purified according to Method A (Et2O eluent), and was isolated as a pink oil
1
(159 mg, 97%). H NMR (400 MHz, CDCl3) δ 9.80 (q, J = 1.5 Hz, 1H), 7.88 – 6.35 (m, 5H),
4.54 (s, 2H), 3.82 (td, J = 6.1, 1.3 Hz, 2H), 2.70 (t, J = 6.1 Hz, 2H). 13C NMR (101 MHz, CDCl3)
δ 201.3, 137.9, 128.6, 127.9, 127.8, 73.4, 64.0, 44.0. Spectral properties are consistent with
literature values.14
Boc-L-tert-leucinal (5)
The product was purified according to Method B (EtOAc organic layer), and was isolated as a
1
white solid (195 mg, 97%). H NMR (400 MHz, CDCl3) δ 9.83 (s, 1H), 5.15 (s, 1H), 4.18 (d, J
13
= 8.7 Hz, 1H), 1.45 (s, 9H), 1.05 (s, 9H). C NMR (101 MHz, CDCl3) δ 201.4, 156.3, 80.2,
67.8, 35.9, 28.6, 27.1. >99% ee based on HPLC analysis. Analysis of % ee is shown in the
HPLC traces of (S)-2-((Boc)amino)-3,3-dimethylbutyl-4-nitrobenzoate (see Supporting
Information). (S)-2-((Boc)amino)-3,3-dimethylbutyl-4-nitrobenzoate was synthesized according
to literature procedure.4 Spectral properties are consistent with literature values.4
1,2:4,5-Di-O-isopropylidene-β-D-erythro-2,3-hexodiulo-2,6-pyranose (6)
The product was purified according to Method A (EtOAc eluent), and was isolated as a white
crystalline solid (246 mg, 95%). 1H NMR (400 MHz, CDCl3) δ 4.73 (d, J = 5.6 Hz, 1H), 4.62 (d,
J = 9.5 Hz, 1H), 4.55 (ddd, J = 5.6, 2.2, 1.0 Hz, 1H), 4.39 (dd, J = 13.5, 2.2 Hz, 1H), 4.12 (d, J =
13.5 Hz, 1H), 4.00 (d, J = 9.5 Hz, 1H), 1.55 (s, 3H), 1.47 (s, 3H), 1.40 (s, 6H). 13C NMR (101
MHz, CDCl3) δ 197.3, 114.2, 111.0, 104.5, 78.3, 76.2, 70.3, 60.4, 27.5, 26.9, 26.41, 26.36.
Spectral properties are consistent with commercially available product.
N-[4-(4-Fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide
(7)
The product was purified according to Method A (CH2Cl2 eluent), and was isolated as a white
1
solid (351 mg, >99%). H NMR (400 MHz, CDCl3) δ 9.97 (s, 1H), 7.68 – 7.58 (m, 2H), 7.26 –
7.19 (m, 2H), 4.01 (hept, J = 6.7 Hz, 1H), 3.64 (s, 3H), 3.55 (s, 3H), 1.32 (d, J = 6.7 Hz, 6H). 13C
ACS Paragon Plus Environment
11